Altered TP receptor function in isolated, perfused kidneys of nondiabetic and diabetic ApoE-deficient mice

American Journal of Physiology - Renal Physiology

Volumn 294, Issue 1, 2008, Pages

  Michel, Frédéric ^a,b   Simonet, Serge ^a   Vayssettes Courchay, Christine ^a   Bertin, Florence ^a   Sansilvestri Morel, Patricia ^a   Bernhardt, Fabienne ^a   Paysant, Jérôme ^a   Silvestre, Jean Sébastien ^b   Levy, Bernard I ^b   Félétou, Michel ^a   Verbeuren, Tony J ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

^b CRC IL 689   (France)

Author keywords

Atherosclerosis; Diabetes; Perfused mouse kidney; Vasoconstriction

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; ANGIOTENSIN II; ARACHIDONIC ACID; ENDOTHELIN; METHOXAMINE; NORADRENALIN; PROSTACYCLIN; THROMBOXANE A2 RECEPTOR;

ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DIABETES MELLITUS; HYPERLIPOPROTEINEMIA TYPE 3; KIDNEY DISEASE; KIDNEY PERFUSION; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN ISOLATION; VASOCONSTRICTION; VASODILATATION;

EID: 38349047991     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00111.2007     Document Type: Article

References (46)

1. Abe T, Takeuchi K, Takahashi N, Tsutsumi E, Taniyama Y, Abe K. Rat kidney thromboxane receptor: molecular cloning, signal transduction, and intrarenal expression localization. J Clin Invest 96: 657-664, 1995.
2. Baggio B, Budakovic A, Casara D, Gambaro G, Saladini G, Piccoli A, Verlato F. Renal involvement in subjects with peripheral atherosclerosis. J Nephrol 14: 286-292, 2001.
3. Belhassen L, Pelle G, Dubois-Rande JL, Adnot S. Improved endothelial function by the thromboxane A2 receptor antagonist S 18886 in patients with coronary artery disease treated with aspirin. J Am Coll Cardiol 41: 1198-204, 2003.
4. Bhardwaj R, Moore PK. Endothelium-derived relaxing factor and the effects of acetylcholine and histamine on resistance blood vessels. Br J Pharmacol 95: 835-843, 1998.
5. Boulanger CM, Morrison KJ, Vanhoutte PM. Mediation by M3-muscarinic receptors of both endothelium-dependent contraction and relaxation to acetylcholine in the aorta of the spontaneously hypertensive rat. Br J Pharmacol 112: 519-524, 1994.
6. Cayatte AJ, Du Y, Olivier-Krasinski J, Lavielle G, Verbeuren TJ, Cohen The Thromboxane A2 receptor antagonist RAS. 18886, but not aspirin inhibits atherogenesis in apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol 20: 1724-1728, 2000.
7. Chade AR, Lerman A, Lerman LO. Kidney in early atherosclerosis. Hypertension 45: 1042-1049, 2005.
8. Chen G, Paka L, Kako Y, Singhal P, Duan W, Pillarisetti S. A protective role for kidney apolipoprotein E. Regulation of mesangial cell proliferation and matrix expansion. J Biol Chem 276: 49142-49147, 2001.
9. Cogolludo A, Frazziano G, Cobeno L, Moreno L, Lodi F, Villamor E, Tamargo J, Perez-Vizcaino F. Role of reactive oxygen species in Kv channel inhibition and vasoconstriction induced by TP receptor activation in rat pulmonary arteries. Ann NY Acad Sci 1091: 41-51, 2006.
10. Collis MG, Vanhoutte PM. Vascular reactivity of isolated perfused kidneys from male and female spontaneously hypertensive rats. Circ Res 41: 759-767, 1977.
11. Crauwels HM, Van Hove CE, Holvoet P, Herman AG, Bult H. Plaque-associated endothelial dysfunction in apolipoprotein E-deficient mice on a regular diet. Effect of human apolipoprotein AI. Cardiovasc Res 59: 189-99, 2003.
12. Craven PA, Melhem MF, DeRubertis FR. Thromboxane in the pathogenesis of glomerular injury in diabetes. Kidney Int 42: 937-946, 1992.
13. Ding H, Hashem M, Wiehler WB, Lau W, Martin J, Reid J, Triggle C. Endothelial dysfunction in the streptozotocin-induced diabetic apoE-deficient mouse. Br J Pharmacol 146: 1110-1118, 2005.
14. Esmatjes E, Conget JI, Gaya J, Fernandez MR, Ferre JP, Rivera F, Vilardell E. Effect of thromboxane synthesis inhibitor trifusal on renal hemodynamics in microalbuminuric diabetic patients. Diabetes Care 13: 1114-1117, 1990.
15. Feletou M, Vanhoutte PM. Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler Thromb Vasc Biol 26: 1215-1225, 2006.
16. Gervais M, Pons S, Nicoletti A, Cosson C, Giudicelli JF, Richer C. Fluvastatin prevents renal dysfunction and vascular NO deficit in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 23: 183-189, 2003.
17. Heuzé-Joubert I, Mennecier P, Simonet S, Laubie M, Verbeuren TJ. Effect of vasodilators, including nitric oxide, on the release of cGMP and cAMP in the isolated perfused rat kidney. Eur J Pharmacol 220: 161-171, 1992.
18. Ishizuka T, Matsui T, Kurita A. Ramatroban, a TP receptor antagonist, improves vascular responses to acetylcholine in hypercholesterolemic rabbits in vivo. Eur J Pharmacol 468: 27-35, 2003.
19. Kawai Y, Ohhashi T. Effects of isocarbacyclin, a stable prostacyclin analogue, on monkey isolated cerebral and peripheral arteries. Br J Pharmacol 112: 635-639, 1994.
20. 2 and prostacyclin in the development of atherosclerosis in apoE-deficient mice. J Clin Invest 114: 784-794, 2004.
21. 2 in the mouse kidney. Am J Physiol Renal Fluid Electrolyte Physiol 271: F1131-F1138, 1996.
22. Morikawa K, Matoba T, Kubota H, Hatanaka M, Fujiki T, Takahashi S, Takeshita A, Shimokawa H. Influence of diabetes mellitus, hypercholesterolemia, and their combination on EDHF-mediated responses in mice. J Cardiovasc Pharmacol 45: 485-490, 2005.
23. Morrow JD. The isoprostanes - unique products of arachidonate peroxidation: their role as mediators of oxidant stress. Curr Pharm Des 12: 895-902, 2006.
24. Oyekan A, Balazy M, McGiff JC. Renal oxygenases: differential contribution to vasoconstriction induced by ET-1 and ANG II. Am J Physiol Regul Integr Comp Physiol 273: R293-R300, 1997.
25. Pratico D, Rokach J, Tangirala RK. Brains of aged apolipoprotein E-deficient mice have increased levels of F2-isoprostanes, in vivo markers of lipid peroxidation. J Neurochem 73: 736-741, 1999.
26. Quilley J, McGiff JC, Nasjletti A. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat. Br J Pharmacol 96: 111-116, 1989.
27. Remuzzi G, FitzGerald GA, Patrono C. Thromboxane synthesis and action within the kidney. Kidney Int 41: 1483-1493, 1992.
28. Renard CB, Kramer F, Johansson F, Lamharzi N, Tannock LR, von Herrath MG, Chait A, Bornfeldt KE. Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions. J Clin Invest 114: 659-668, 2004.
29. Shibouta Y, Terashita ZI, Inada Y, Nishikawa K, Kikuchi S. Enhanced thromboxane A2 biosynthesis in the kidney of spontaneously hypertensive rats during development of hypertension. Eur J Pharmacol 70: 247-256, 1981.
30. Silldorff EP, Hilbun LR, Pallone TL. Angiotensin II constriction of rat vasa recta is partially thromboxane dependent. Hypertension 40: 541-546, 2002.
31. Simonet S, Descombes JJ, Vallez MO, Dubuffet T, Lavielle G, Verbeuren TJ. S 18886, a new thromboxane (TP)-receptor antagonist is the active isomer of S 18204 in all species, except in the guinea-pig. In: Recent Advances in Prostaglandin, Thromboxane, and Leukotriene Research, edited by Sinzinger H, Samuelsson B, Vane Sir John R, and Paoletti R. New York. Plenum, 1998, p. 173-176,
32. Valentin F, Field MC, Tippins JR. The mechanism of oxidative stress stabilization of the thromboxane receptor in COS-7 cells. J Biol Chem 279: 8316-8324, 2004.
33. Verbeuren TJ, Jordaens FH, Zonnekeyn LL, Van Hove CE, Coene MC, Herman AG. Effect of hypercholesterolemia on vascular reactivity in the rabbit. I. Endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits. Circ Res 58: 552-564, 1986.
34. Verbeuren TJ, Mennecier P, Laubie M. 5-Hydroxytryptamine-induced vasodilatation in the isolated perfused rat kidney: are endothelial 5-HT1A receptors involved? Eur J Pharmacol 201: 17-27, 1991.
35. Verbeuren TJ, Mennecier P, Merceron D, Simonet S, de Nanteuil G, Vincent M, Laubie M. Phosphoramidon inhibits the conversion of Big ET-1 into ET-1 in the pithed rat and in isolated perfused rat kidneys. J Cardiovasc Pharmacol 22: S81-S84, 1993.
36. Verbeuren TJ, Vallez MO, Lavielle G, Bouskela E. Activation of thromboxane receptors and the induction of vasomotion in the hamster check pouch microcirculation. Br J Pharmacol 122: 859-866, 1997.
37. Villeneuve N, Fortuno A, Sauvage M, Fournier N, Breugnot C, Jacquemin C, Petit C, Gosgnach W, Carpentier N, Vanhoutte P, Vilaine JP. Persistence of the nitric oxide pathway in the aorta of hypercholesterolemic apolipoprotein E-deficient mice. J Vasc Res 40: 87-96, 2003.
38. Vonend O, Stegbauer J, Sojka J, Habbel S, Quack I, Robaye B, Boeynaems JM, Rump LC. Noradrenaline and extracellular nucleotide cotransmission involves activation of vasoconstrictive P2X(1,3)- and P2Y6-like receptors in mouse perfused kidney. Br J Pharmacol 145: 66-74, 2005.
39. Webb RC, Johnson JC, Vander AJ, Henry JP. Increased vascular sensitivity to angiotensin II in psychosocial hypertensive mice. Hypertension 5: I165-I169, 1983.
40. Wilson SJ, McGinley K, Huang AJ, Smyth EM. Heterodimerization of the alpha and beta isoforms of the human thromboxane receptor enhances isoprostane signaling. Biochem Biophys Res Commun 352: 397-403, 2007.
41. Xu S, Jiang Maitland KA B, Bayat H, Gu J, Nadler JL, Corda S, Lavielle G, Verbeuren TJ, Zuccollo A, Cohen RA. The thromboxane receptor antagonist S 18886 attenuates renal oxidant stress and proteinuria in diabetic apolipoprotein E-deficient mice. Diabetes 55: 110-119, 2006.
42. Yaghoubi M, Oliver-Krasinski J, Cayatte AJ, Cohen RA. Decreased sensitivity to nitric oxide in the aorta of severely hypercholesterolemic apolipoprotein E deficient mice. J Cardiovasc Pharmacol 36: 751-757, 2000.
43. Yang D, Feletou M, Boulanger CM, Wu HF, Levens N, Zhang JN, Vanhoutte PM. Oxygen-derived free radicals mediate endothelium-dependant contractions to acetylcholine in aortas from spontaneously hypertensive rats. Br J Pharmacol 136: 104-110, 2002.
44. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258: 468-471, 1992.
45. Zhou Y, Varadharaj S, Zhao X, Parinandi N, Flavahan NA, Zweier JL. Acetylcholine causes endothelium-dependent contraction of mouse arteries. Am J Physiol Heart Circ Physiol 289: H1027-H1032, 2005.
46. 2 receptor antagonist S 18886 prevents enhanced atherogenesis caused by diabetes mellitus. Circulation 112: 3001-3008, 2005.